Pharmacokinetics of LCQ908 in Patients With Hepatic Impairment

Clinical trial NCT01594957 · COMPLETED

Trial details

NCT number: NCT01594957
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatic Impairment

Start date: 2012-04-01
Primary completion: 2013-04-01
Enrollment: 53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.